Cardiovascular events and all-cause mortality: effects of dual therapy intensification with insulin vs glucagon-like peptide-1 analogue

Sep-15

Cardiovascular Endocrinology Pharmacoepidemiology

AUTHORS : Dr Iskandar Idris, University of Nottingham, Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, Royal Derby Hospital , Uttoxeter Road, Derby DE22 3DT – Email: Iskandar.Idris@nottingham.ac.uk – Profile: https://www.nottingham.ac.uk/medicine/people/iskandar.idris – Cannot find much information on Uchenna Anyanwagu, Division of Medical Sciences & Graduate Entry Medicine, School of Medicine, University of Nottingham, United Kingdom – Profile (publons): https://publons.com/researcher/1239992/uchenna-anyanwagu/

JOURNAL : Diabetologia

REFERENCE: 58(S1):S452

DOI : 10.1007/s00125-015-3687-4

Cardiovascular events and all-cause mortality: effects of dual therapy intensification with insulin vs glucagon-like peptide-1 analogue

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study